Medication effect on lymphocyte morphology in schizophrenia - PubMed (original) (raw)
Comparative Study
. 1989 Jul-Oct;2(4-5):385-90.
doi: 10.1016/0920-9964(89)90031-5.
Affiliations
- PMID: 2577275
- DOI: 10.1016/0920-9964(89)90031-5
Comparative Study
Medication effect on lymphocyte morphology in schizophrenia
E F Torrey et al. Schizophr Res. 1989 Jul-Oct.
Abstract
Past studies on the occurrence of atypical lymphocytes in the blood of individuals with schizophrenia are contradictory; some researchers have argued that such cells are a genetic marker of the disease while others have explained the cells simply as an effect of antipsychotic drugs. The present study blindly measured atypical lymphocytes in 14 schizophrenics on medication for at least 6 weeks and off medication for at least 4 weeks, ten Huntington's disease patients on antipsychotic medication, and ten normal controls. The patients with schizophrenia (P less than 0.05) and those with Huntington's disease (P less than 0.02) both had significantly more atypical lymphocytes than the normal controls. However no difference was found in the percentage of atypical lymphocytes in patients with schizophrenia on and off medication. The authors cite the need for studies of first-admission, never-tested patients to definitively settle this question.
Similar articles
- [Peripheral blood T-lymphocyte and T-lymphocyte subset ratios before and after treatment in schizophrenia patients not taking antipsychotic medication].
Baskak SC, Ozsan H, Baskak B, Devrimci Ozgüven H, Kinikli G. Baskak SC, et al. Turk Psikiyatri Derg. 2008 Spring;19(1):5-12. Turk Psikiyatri Derg. 2008. PMID: 18330738 Turkish. - Neuroleptic treatment is an unlikely cause of elevated dopamine in thalamus of schizophrenic subjects.
Oke AF, Putz C, Adams RN, Bird ED. Oke AF, et al. Psychiatry Res. 1992 Dec;45(4):203-8. doi: 10.1016/0925-4927(92)90015-v. Psychiatry Res. 1992. PMID: 1363335 - Stimulated lymphocytes in schizophrenia.
Hirata-Hibi M, Higashi S, Tachibana T, Watanabe N. Hirata-Hibi M, et al. Arch Gen Psychiatry. 1982 Jan;39(1):82-7. doi: 10.1001/archpsyc.1982.04290010058011. Arch Gen Psychiatry. 1982. PMID: 6119967 - Combination of "atypical" antipsychotic medication in the management of treatment-resistant schizophrenia and schizoaffective disorder.
Lerner V, Libov I, Kotler M, Strous RD. Lerner V, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2004 Jan;28(1):89-98. doi: 10.1016/j.pnpbp.2003.09.024. Prog Neuropsychopharmacol Biol Psychiatry. 2004. PMID: 14687862 Review.
Cited by
- Cerebrospinal fluid markers of inflammation and infections in schizophrenia and affective disorders: a systematic review and meta-analysis.
Orlovska-Waast S, Köhler-Forsberg O, Brix SW, Nordentoft M, Kondziella D, Krogh J, Benros ME. Orlovska-Waast S, et al. Mol Psychiatry. 2019 Jun;24(6):869-887. doi: 10.1038/s41380-018-0220-4. Epub 2018 Aug 16. Mol Psychiatry. 2019. PMID: 30116031 Free PMC article. - Telomerase levels in schizophrenia: a preliminary study.
Porton B, Delisi LE, Bertisch HC, Ji F, Gordon D, Li P, Benedict MM, Greenberg WM, Kao HT. Porton B, et al. Schizophr Res. 2008 Dec;106(2-3):242-7. doi: 10.1016/j.schres.2008.08.028. Epub 2008 Oct 1. Schizophr Res. 2008. PMID: 18829263 Free PMC article. - Elevated Le(y) antigen expression on T-lymphocytes in schizophrenic patients.
Kokai M, Hirata I, Adachi M, Hatotani N, Hakomori S, Tachibana T. Kokai M, et al. Eur Arch Psychiatry Clin Neurosci. 1993;243(2):82-6. doi: 10.1007/BF02191569. Eur Arch Psychiatry Clin Neurosci. 1993. PMID: 8218431 - Viruses, schizophrenia, and bipolar disorder.
Yolken RH, Torrey EF. Yolken RH, et al. Clin Microbiol Rev. 1995 Jan;8(1):131-45. doi: 10.1128/CMR.8.1.131. Clin Microbiol Rev. 1995. PMID: 7704891 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous